SciELO - Scientific Electronic Library Online

 
vol.28 número1Queratopatía cristalina en EL-DSEK índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Oftalmología

versão On-line ISSN 1561-3070

Resumo

QUINTERO BUSUTIL, Mayrelis et al. Vogt-Koyanagi-Harada disease and visual rehabilitation. Rev Cubana Oftalmol [online]. 2015, vol.28, n.1, pp. 0-0. ISSN 1561-3070.

Vogt-Koyanagi-Harada (VKH) is a rare, multisystemic, allegedly autoimmune disease of unknown etiology. It is characterized by chronic bilateral granulomatous and diffuse panuveitis, accompanied by tegumentary, neurological and hearing impairments that often affect the non-Caucasians and usually women. It usually occurs in the 20-25 years age group and its incidence varies with the geographic location. It is estimated that 25% of the patients with this disease are legally blind, the other 25% may have low vision and 50% present with visual acuity over 20/50. There is a 50 years-old patient with a history of Vogt - Koyanagi - Harada disease for 8 years. He had been treated with systemic steroid anti-inflammatory drugs and immunosuppressive therapy as well as supporting therapy with topical and cycloplegic steroid anti-inflammatories. The patient had gone to the low vision service looking for rehabilitation. He was performed a complete eye examination, supplementary studies and he was finally rehabilitated through the use of optical and non-optical aids in order to maximize his remaining vision.

Palavras-chave : Vogt-Koyanagi-Harada disease; optical aid; non-optical aid; low vision; legally blind; visual rehabilitation.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License